<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> represents the most common form of clinical <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> in daily routine </plain></SENT>
<SENT sid="1" pm="."><plain>However, current therapeutic options are still limited and a better understanding of the underlying molecular mechanisms is expected to contribute to the development of new therapeutic strategies </plain></SENT>
<SENT sid="2" pm="."><plain>The scientific field of microRNA research has received a lot of attention in recent years, especially regarding cardiovascular research </plain></SENT>
<SENT sid="3" pm="."><plain>This article gives a brief overview of the most recent developments in microRNA research in the field of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> and atrial remodelling processes </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, the clinical perspective of microRNAs as new therapeutic targets and as potential biomarkers is discussed </plain></SENT>
</text></document>